Literature DB >> 8837630

Differences between studies in reported relative risks associated with smoking: an overview.

P J van de Mheen1, L J Gunning-Schepers.   

Abstract

Reported Relative Risks associated with smoking differ between studies; these differences may reflect true biological differences between populations or may be research artifacts introduced by differences in factors such as amount smoked or smoking duration. The authors reviewed the literature published before June 1992 on relative risks associated with smoking for heart disease, stroke, lung cancer, and chronic obstructive lung disease. They quantified the effect of variables such as age, amount smoked, and smoking duration on reported relative risks. The main reasons for the variation in reported relative risks were: misclassification of former smokers as never smokers, the use of mortality rate ratios rather than incidence rate ratios, a possible period effect suggesting increasing relative risks over time, and differences in the amounts smoked. It is far more likely that these factors are responsible for the observed variation between studies than that the variations reflect true biological differences between populations. Using relative risks from other studies is therefore justified in calculating a population attributable risk if the studies are carefully selected and address factors such as amount smoked and period effects.

Entities:  

Keywords:  Behavior; Comparative Studies; Demographic Factors; Developed Countries; Error Sources; Health; Literature Review; Measurement; Population; Population Dynamics; Research Methodology; Smoking; Studies; Time Factors

Mesh:

Year:  1996        PMID: 8837630      PMCID: PMC1381785     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  29 in total

1.  Mortality experience among the Japanese in the United States, Hawaii, and Japan.

Authors:  T GORDON
Journal:  Public Health Rep       Date:  1957-06       Impact factor: 2.792

2.  Smoking and mortality among older men and women in three communities.

Authors:  A Z LaCroix; J Lang; P Scherr; R B Wallace; J Cornoni-Huntley; L Berkman; J D Curb; D Evans; C H Hennekens
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

3.  Timeless epidemiology or history cannot be ignored.

Authors:  L J Gunning-Schepers; J J Barendregt
Journal:  J Clin Epidemiol       Date:  1992-04       Impact factor: 6.437

4.  Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of "high-risk" and "population-based" approaches to prevention of cardiovascular disease.

Authors:  D Strachan; G Rose
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

5.  Incidence of coronary heart disease in a population insured for medical care (HIP): myocardial infarction, angina pectoris, and possible myocardial infarction.

Authors:  S Shapiro; E Weinblatt; C W Frank; R V Sager
Journal:  Am J Public Health Nations Health       Date:  1969

6.  Mortality in relation to smoking: 40 years' observations on male British doctors.

Authors:  R Doll; R Peto; K Wheatley; R Gray; I Sutherland
Journal:  BMJ       Date:  1994-10-08

7.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors.

Authors:  M G Marmot; S L Syme; A Kagan; H Kato; J B Cohen; J Belsky
Journal:  Am J Epidemiol       Date:  1975-12       Impact factor: 4.897

8.  Smoking cessation in relation to total mortality rates in women. A prospective cohort study.

Authors:  I Kawachi; G A Colditz; M J Stampfer; W C Willett; J E Manson; B Rosner; D J Hunter; C H Hennekens; F E Speizer
Journal:  Ann Intern Med       Date:  1993-11-15       Impact factor: 25.391

9.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?

Authors:  D R Shopland; H J Eyre; T F Pechacek
Journal:  J Natl Cancer Inst       Date:  1991-08-21       Impact factor: 13.506

Review 10.  Variation in reported prevalences of hypertension in The Netherlands: the impact of methodological variables.

Authors:  P J van de Mheen; L Bonneux; L J Gunning-Schepers
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

View more
  7 in total

1.  What Is the Relative Risk of Disease in Smokers?

Authors:  Miriam K Campbell
Journal:  Public Health Rep       Date:  1996-09       Impact factor: 2.792

2.  Summary of scientific evidence.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  2002-02

3.  Health risks in the cleaning industry: a Belgian census-linked mortality study (1991-2011).

Authors:  Laura Van den Borre; Patrick Deboosere
Journal:  Int Arch Occup Environ Health       Date:  2017-08-14       Impact factor: 3.015

4.  Chapter 10: A macro-model of smoking and lung cancer: examining aggregate trends in lung cancer rates using the CPS-I and CPS-II and two-stage clonal expansion models.

Authors:  David T Levy; Kenneth Blackman; Eduard Zaloshnja
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

Review 5.  Smoking and ischemic heart disease disparities between studies, genders, times, and socioeconomic strata.

Authors:  Bruce N Leistikow
Journal:  J Cardiovasc Transl Res       Date:  2009-06-30       Impact factor: 4.132

6.  Associations between cigarette smoking and total mortality differ depending on serum concentrations of persistent organic pollutants among the elderly.

Authors:  Yu-Mi Lee; Sang-Geun Bae; Seon-Hwa Lee; David R Jacobs; Duk-Hee Lee
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

7.  Does mortality risk of cigarette smoking depend on serum concentrations of persistent organic pollutants? Prospective investigation of the vasculature in Uppsala seniors (PIVUS) study.

Authors:  Duk-Hee Lee; Lars Lind; David R Jacobs; Samira Salihovic; Bert van Bavel; P Monica Lind
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.